Engineering human dendritic cells for tolerogenic gene therapy of type 1 diabetes [ 2019 - ]

Research Grant

Brief description Type 1 diabetes (T1D) afflicts more than 100,000 Australians and results from autoimmune destruction of insulin producing beta-cells. Insulin injections are required for survival, but T1D leads to substantial illness and reduced life expectancy. This project will test a newly-developed immunotherapeutic approach in a humanized mouse model of disease. Successful completion would accelerate the translation of this approach as a potential cure for T1D.

Funding Amount $831,653.00

Funding Scheme Project Grants

Notes Standard Project Grant